A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, ...

In an interview with Targeted Oncology, C. Ola Langren, MD, PhD, discussed the continuing impact of the groundbreaking FDA ...

Jim Delaney, 66, who lives in Edinburgh, had noticed subtle signs leading up to the festive period, including unexplained ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...

When he struggled to eat his favourite meal of the year - his Christmas dinner - the Edinburgh siblings urged Jim to go to ...

Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and progresses from precancerous to malignant states by tracing DNA ...

At COMy 2025, researchers highlighted barriers to EMA-approved CAR T-cell therapy access due to age, comorbidities, and ...

An innovative blood cancer treatment regime could extend remission by seven months on average, according to the findings of a ...

Ronnie was taken to A&E when his health deteriorated and was given the devastating diagnosis. Just days after starting ...